NPI: 1619939311 · MORTON, PA 19070 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/06/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/06/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,864 | $2K |
| 2020 | 1,656 | $108K |
| 2021 | 5,034 | $457K |
| 2022 | 4,270 | $483K |
| 2023 | 4,964 | $531K |
| 2024 | 4,817 | $500K |
| Code | Description | Claims | Bene. Records | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,458 | 1,536 | $2.08M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 3,472 | 195 | $2K |
| G0008 | Administration of influenza virus vaccine | 12 | 12 | $42.54 |
| J1756 | Injection, iron sucrose, 1 mg | 1,550 | 377 | $0.00 |
| 85048 | 355 | 331 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 1,460 | 129 | $0.00 |
| 85041 | 355 | 331 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 463 | 265 | $0.00 |
| 83970 | 370 | 345 | $0.00 | |
| 82108 | 77 | 68 | $0.00 | |
| 83540 | 225 | 207 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 1,045 | 474 | $0.00 |
| 83550 | 224 | 206 | $0.00 | |
| 82728 | 205 | 192 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 2,298 | 180 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 36 | 35 | $0.00 |